van der Kamp Hilde Johanna
SEC CIK 2000565 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | Dir | 10.4K | — | — | 2 | 2025-01-07 | 2026-01-07 |
Most active insiders at NAMS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davidson Michael H. | CEO, Dir | $226.5K | $25.33M |
| 2 | Kooij Louise Frederika | CAO | — | $16.75M |
| 3 | Kastelein Johannes Jacob Pieter | CSO, Dir | — | $14.26M |
| 4 | Somaiya Mayur Ian | CFO | — | $3.43M |
| 5 | LANGE LOUIS G | Dir | — | $2.19M |
| 6 | Smither John W | Dir | — | $40.5K |
| 7 | Gunning Robert William | VP, Ctrl | — | — |
| 8 | van der Kamp Hilde Johanna | Dir | — | — |
| 9 | McKenna Mark C. | Dir | — | — |
| 10 | Gulfo Adele M. | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-09 | 2026-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | van der Kamp Hilde Johanna | Dir | A - Grant | — | +3,400 | 10.4K | +49% | — |
| D | 2025-01-08 | 2025-01-07 | NAMS | NewAmsterdam Pharma Co N.V. | van der Kamp Hilde Johanna | Dir | A - Grant | — | +6,960 | 6,960 | New | — |
Purchase Sale Sale after option exercise All abbreviations